Dr Lal PathLabs Ltd experienced a breakout from an inverse Head & Shoulder pattern, indicating a potential trend reversal. Experts recommend short-to-medium term traders to buy on dips, targeting above Rs 3,700. The stock has rebounded multiple times, most recently climbing above Rs 3,000 in July 2024, suggesting stronger support and potential upward momentum.